For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 Dose Certain Phase III Clinical Research in Children Under the Age of 18 Years Old
Phase of Trial: Phase III
Latest Information Update: 17 Apr 2018
At a glance
- Drugs Mycobacterium riyadhense (Primary)
- Indications Tuberculosis
- Focus Diagnostic use
- Sponsors AnHui Longcom Biologic Pharmacy
- 10 Apr 2018 Status changed from recruiting to completed.
- 31 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 16 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.